Copyright
©The Author(s) 2019.
World J Gastroenterol. Mar 14, 2019; 25(10): 1185-1196
Published online Mar 14, 2019. doi: 10.3748/wjg.v25.i10.1185
Published online Mar 14, 2019. doi: 10.3748/wjg.v25.i10.1185
Disease phenotype | Symptoms | Pathophysiology | Diagnosis | Treatment options or selections |
Functional dyspepsia | Postprandial fullness, early satiety; Epigastric pain, epigastric burning | Alterations in gastric emptying and/or gastric accommodation | Gastric emptying study; Gastric accommodation studies (SPECT, MR imaging) | Reduced GE and/or GA → prokinetic or gastric relaxants; Normal GE and GA → central pain modulator |
Outlet dysfunction constipation | Constipation, abdominal pain | Pelvic floor dyssynergia | Anorectal manometry with balloon expulsion test; MR defecography | Pelvic floor rehabilitation with biofeedback training |
Slow transit constipation | Constipation, abdominal pain | Decreased colonic motility | Colon transit studies with radiopaque markers or scintigraphy or wireless motility capsule | Prokinetic agents; Secretory + stimulant laxatives; Total colectomy with ileo-rectal anastomosis |
Bile acid diarrhea | Diarrhea; Abdominal pain | Increased bile acid synthesis/ decreased bile acid absorption | Total fecal bile acids; Fecal bile acid composition; Serum 7-α-hydroxy-4-cholesten-3-one | Bile acid binders |
- Citation: Wang XJ, Camilleri M. Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy. World J Gastroenterol 2019; 25(10): 1185-1196
- URL: https://www.wjgnet.com/1007-9327/full/v25/i10/1185.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i10.1185